Yesterday the work package leaders of the PHOENIX OITB project met at the facilities of MyBiotech GmbH in Überherrn, Germany with our project advisor and monitor for our M36 Review Meeting. We are grateful for the good questions, suggestions and constructive criticism.

Last month, Akif Emre Türeli MyBiotech GmbH traveled to Los Angeles to present PHOENIX at the Drug Delivery Summit. Great opportunity to gain insights into the US market and bring attention to European innovation, PHOENIX & our Single Entry Point for nanopharmaceutical development.

At the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (#PBPWorldMeeting) in Vienna from 18-21 March, Susanne Resch of BNN presented a poster for PHOENIX-OITB. The event attracted hundreds from industry and research in pharma.

PHOENIX OITB was well represented in the the latest BNN QUARTERLY! Take a look here: issuu.com/bnn-bionanonet… Don't forget to subscribe to get 4 issues a year to your inbox: mailchi.mp/986d2c1e28e1/b…

Less than 1 month to go! Apply by May 3rd to receive funded access to a broad range of services in nanopharmaceutical development! #H2020 #funding #OpenCall #Nanopharmaceuticals

PHOENIX will be represented at #ETPN2024 by Susanne Resch of BNN. Take advantage of the early bird deadline and learn more about #nanomedicine and our single entry point for #nanopharmaceutical innovation: PHOENIX SEP!

Curious if the PHOENIX Open Call is right for you? Our interview with Scientific Coordinator Nazende GündayTüreli shows potential applicants the process for getting funded services in nanopharmaceutical development! phoenix-oitb.eu/phoenix-oitb-2… #h2020 #EUfunding #GMP

Thank you #IndTech2024 for having our scientific coordinator Nazende GündayTüreli present PHOENIX at the #OITB satellit event today in Namur🇧🇪 Great to network and share knowledge & experience with other Open Innovation Test Beds. PHOENIX Single Entry Point: phoenix-sep.com

Lange Nacht der Forschung in 🇦🇹: In Linz, RECENDT explained non-destructive testing & measurement of food products or #nanoparticles. In Graz, RCPE used muesli & candy to show features of #nanopharmaceutical production while BNN let kids discover #nano in nature.

We're introducing PHOENIX to the pharma industry and SMEs interested accessing services in #nanopharmaceutical development from a Single-Entry-Point! Join us in Graz 🇦🇹 on Friday, Sept 13th, 10am-1pm followed by a networking lunch. Register here: lnkd.in/dBYK-kbk

*Important announcement: Satellite Event moved ONLINE!* Due to requests to expand our introductory event of the PHOENIX-OITB services to a wider audience, we have decided to move the event entirely online! ➡️Register here: lnkd.in/dg-sqtmV

The Agenda for our webinar is here! Register now to hear from our speakers about the services of the PHOENIX-OITB, and how they can benefit companies and researchers. #OITB #nanopharmaceuticals #nanomedicine #pharma #CMC #characterization #regulation #regulatorycompliance

Our upcoming webinar speakers represent our 5 service areas: - Physico-chemical characterization - In vitro characterization - In vivo characterization - Manufacturing - Regulatory support (Not pictured: speaker Johannes Khinast RCPE ) Register now! phoenix-oitb.eu/satellite-even…

Are you at #CPHIMilan this week? Visit PHOENIX partner Nanomol Technologies at stand 18C7, zone Pharma Machinery and Equipment, to learn more about PHOENIX services for #nanopharmaceutical development! Find out more about them via their video: youtu.be/EReESsGKRmU?si…

Thrilled to have 2 partners together at #PODD2024 - Partnership Opportunities in Drug Delivery - in #Boston! Visit us at: Nanomol Technologies (Booth 48) and MyBiotech GmbH (Booth 12) to learn about the PHOENIX-OITB services accessed via our single entry point, PHOENIX SEP.

A valuable day spent with the #NABIHEAL team in Barcelona: yacine hachemi & IMI organized a workshop on regulatory frameworks for #medicaldevices containing #nanomaterials and for #nanomedicines. Thanks to all involved! 👏

This year we have 3 partners on Stanford's "Top 2% Scientists" list. Congrats to - Ivana Vinković Vrček (IMI), - Johannes Khinast (RCPE ) for making the 2024 list, and - Jesus M de la Fuente (CSIC) for making the "career-long" list of top-cited resesarchers! 🔬 🎉

PHOENIX was represented last week in the stunning Kuppelsaal of TU Wien at the acib Mini-Symposium "Enhanced Sustainability in Pharma". PHOENIX services were presented in an overview of initiatives with ties to Austria, and we welcomed interested attendees to our booth.

Topas Therapeutics is focused on developing nanoparticle-based drug products to address areas of major unmet need, including autoimmune diseases. Watch our interview to learn how they used the services of PHOENIX-OITB guided by PHOENIX SEP: youtu.be/0LeKWzoV5H0?fe…

Stay with us! The PHOENIX consortium met in Madrid at CSIC to discuss the future of our project & the PHOENIX SEP. We're leaving this platform. Make sure to follow our news via PHOENIX OITB & PHOENIX SEP on LinkedIn. Or subscribe to our newsletter! phoenix-sep.com/contact/